Price chart (1D to 10Y)
Licensed market data — shown to members, not published to the open web.
Portfolio · 31 May 2026
From the fund’s own N-PORT filingThe fund’s disclosed portfolio, not an index membership list. Showing the largest 25 of 267 positions. The ten largest identified positions carry 42.9% of the portfolio.
| # | Holding | Sector | Country | Weight | Filed value |
|---|---|---|---|---|---|
| 1 | N/A | — | United States | 7.35% | $5.41M |
| 2 | ProShares GENIUS Money Market ETF IQMM | — | United States | 6.79% | $5.00M |
| 3 | Gilead Sciences, Inc. GILD | Healthcare | United States | 4.66% | $3.43M |
| 4 | Vertex Pharmaceuticals, Inc. VRTX | Healthcare | United States | 4.65% | $3.42M |
| 5 | Amgen, Inc. AMGN | Healthcare | United States | 4.48% | $3.30M |
| 6 | N/A | — | United States | 3.94% | $2.90M |
| 7 | N/A | — | United States | 3.26% | $2.40M |
Source: SEC filings. Information and analytics, not investment advice.